Denied for Evrysdi (Risdiplam) by Cigna in Illinois? Complete Appeal Guide (Forms, Timelines & Scripts)

Answer Box: Getting Evrysdi (Risdiplam) Covered by Cigna in Illinois

Cigna requires prior authorization (PA) for Evrysdi with genetic confirmation of 5q-SMA, baseline motor assessment, and neurologist prescription. If denied, file internal appeals within 180 days; Cigna must respond in 15 business days. Illinois residents get automatic external review by independent specialists (5-day binding decisions) starting 2025. First step: verify coverage via Cigna member portal and obtain PA forms from your neurologist today.

Table of Contents

  1. Understanding Your Denial
  2. Coverage Requirements at a Glance
  3. Step-by-Step: Fastest Path to Approval
  4. Common Denial Reasons & Fixes
  5. Appeals Playbook for Illinois
  6. Scripts & Templates
  7. When to Escalate
  8. Costs & Savings Options
  9. FAQ

Understanding Your Denial

When Cigna denies Evrysdi (risdiplam), the denial letter contains crucial information you'll need for your appeal. Look for these key elements:

Decode the denial reason:

  • Missing genetic confirmation of 5q-SMA diagnosis
  • Insufficient baseline motor assessment documentation
  • Step therapy requirements (trial of alternatives like Spinraza)
  • Dosing or weight calculation gaps
  • Duplicate therapy concerns with other SMA treatments

Extract critical deadlines: Illinois law gives you 180 days to file an internal appeal from the denial date. Mark this deadline immediately—it's shorter than many other states for external review (30 days after final internal denial).

Determine coverage level: Evrysdi is typically covered under Cigna's specialty pharmacy benefit through Express Scripts/Accredo, not your standard pharmacy benefit. This affects which forms and processes apply.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization PA required before coverage Cigna member portal or call member services Cigna PA Policy
Genetic Testing SMN1 biallelic deletion/mutation from CLIA lab Neurologist's records FDA Label
Baseline Motor Assessment CHOP-INTEND, HFMSE, MFM-32, RULM, or BSID-III scores Clinical documentation Cigna Coverage Criteria
Specialist Prescription Neurologist must prescribe with weight-based dosing Doctor's office Prescriber Resources
Appeals Deadline 180 days for internal appeal in Illinois Denial letter date Illinois Insurance Code

Step-by-Step: Fastest Path to Approval

1. Verify Coverage and Obtain Forms

Who: Patient or caregiver
Document needed: Insurance card, member ID
How to submit: Log into Cigna member portal or call member services
Timeline: Same day
Source: Cigna Member Portal

2. Gather Required Documentation

Who: Neurologist's office
Documents needed:

  • Genetic test report confirming SMN1 deletion/mutation
  • Clinical notes with SMA type and ICD-10 codes (G12.0 Type 1; G12.1 Types 2-4)
  • Baseline motor function scores with dates
  • Current weight and dose calculation (0.2 mg/kg daily for 2 months to <2 years)
  • Treatment history and contraindications to alternatives

Timeline: 1-2 weeks to compile
Source: Cigna PA Requirements

3. Submit Prior Authorization

Who: Neurologist or office staff
How to submit: CoverMyMeds, Cigna provider portal, or fax to Express Scripts
Timeline: 5-14 business days for standard review; 24-72 hours for expedited
Source: Express Scripts PA Process

4. Request Peer-to-Peer if Denied

Who: Prescribing neurologist
How: Call Cigna medical director within 5-7 days of denial
Success rate: 80%+ approval rate for documented medical necessity
Timeline: Usually scheduled within 24-48 hours

5. File Internal Appeal if Needed

Who: Patient, caregiver, or authorized representative
Documents: Denial letter, additional clinical evidence, medical necessity letter
How: Cigna Forms Center or member portal
Timeline: 15 business days for Cigna response
Source: Cigna Appeals Process

6. Pursue External Review (Illinois-Specific)

Who: Patient or representative
When: Within 30 days of final internal denial
How: Illinois Department of Insurance or automatic enrollment (2025+)
Timeline: 5 business days for binding decision
Source: Illinois DOI External Review

Common Denial Reasons & Fixes

Denial Reason How to Overturn Documents to Include
Insufficient genetic documentation Submit complete CLIA lab report with SMN1/SMN2 copy number details Full genetic test results, not just summary
Missing baseline motor assessment Include validated scale scores (CHOP-INTEND, HFMSE, etc.) with dates Motor function evaluations from neurologist
Step therapy failure not documented Provide exception letter citing contraindications or prior failures Medical records showing Spinraza intolerance/ineffectiveness
Incomplete dosing information Submit weight-based calculation worksheet Current weight, dose calculation, administration plan
Duplicate therapy concerns Clarify discontinuation of other SMA treatments Treatment timeline showing transition plan
From Our Advocates: We've seen many Illinois families succeed by requesting a peer-to-peer review immediately after denial. One family's neurologist provided compelling evidence about rapid motor decline in their toddler with Type 1 SMA, emphasizing that Evrysdi's oral administration was crucial given the child's difficulty with intrathecal injections. The medical director approved coverage within 24 hours of the call.

Appeals Playbook for Illinois

Internal Appeals

  • Deadline: 180 days from denial date
  • Response time: 15 business days (24 hours if expedited)
  • How to file: Cigna member portal, mail, or fax
  • Required: Denial letter, additional medical evidence, appeal form
  • Expedited criteria: Delay would seriously jeopardize life or health

External Review (Illinois-Specific Rights)

Illinois provides stronger appeal rights than many states through the Health Carrier External Review Act:

  • Automatic enrollment: Starting 2025, upheld medical necessity denials trigger automatic external review
  • Timeline: 30 days to request (shorter than federal 4-month window)
  • Decision time: 5 business days after IRO receives complete file
  • Reviewer: Board-certified physician with SMA/neuromuscular expertise
  • Binding: Insurance company must cover if IRO approves
  • Cost: Free to patients; insurers pay IRO fees
  • Penalties: Up to $50,000 for insurer non-compliance (2025 update)

Contact Illinois Department of Insurance:

Illinois Attorney General Health Care Bureau:

  • Helpline: (877) 305-5145
  • Can intervene informally with insurers

Counterforce Health helps families navigate these complex appeal processes by turning insurance denials into targeted, evidence-backed appeals. The platform identifies denial reasons and drafts point-by-point rebuttals aligned to each plan's specific requirements, pulling the right medical citations and clinical evidence needed for SMA treatments like Evrysdi.

Scripts & Templates

Patient Phone Script for Cigna

"Hello, I'm calling about a prior authorization denial for Evrysdi for my [child/myself] with spinal muscular atrophy. The denial reference number is [number]. I'd like to request a peer-to-peer review with a medical director and understand my appeal options. Can you also confirm the exact deadline for filing an internal appeal? I'm in Illinois, so I want to make sure I understand my state-specific rights."

Medical Necessity Letter Template (for Clinicians)

Patient Problem: "[Patient name] has genetically confirmed 5q-SMA Type [X] with documented motor decline/risk as evidenced by [specific motor scores/clinical findings]."

Prior Treatments: "Previous therapies attempted include [list with dates, outcomes, and reasons for discontinuation/contraindication]."

Clinical Rationale: "Evrysdi is medically necessary because [specific clinical reasons, FDA-approved indication, inability to use alternatives]."

Guideline Citations: Reference FDA labeling, SMA care guidelines, and peer-reviewed literature supporting oral SMN2 splicing modifier therapy.

Appeal Letter Framework

  1. Opening: State you're appealing the denial dated [date] for Evrysdi
  2. Medical necessity: Explain why Evrysdi is essential for this patient's SMA
  3. Address denial reason: Point-by-point rebuttal with supporting documentation
  4. Clinical evidence: Attach genetic testing, motor assessments, specialist notes
  5. Conclusion: Request immediate approval and expedited review if applicable

When to Escalate

Contact regulators if:

  • Cigna misses appeal deadlines (15 business days internal, 5 days external)
  • Denial appears to contradict written policy
  • You're not receiving required notices or forms
  • External review decision is ignored

File complaints with:

  • Illinois Department of Insurance: (877) 527-9431
  • Illinois Attorney General: (877) 305-5145
  • Federal complaint (if applicable): CMS Medicare complaints

Costs & Savings Options

While working on coverage, explore financial assistance:

Manufacturer Support:

  • Genentech Patient Foundation: Income-based assistance
  • Evrysdi Access Solutions: Copay support and prior authorization help
  • Contact: Evrysdi Patient Resources

State Programs:

  • Illinois Medicaid: Expanded coverage for eligible families
  • State pharmaceutical assistance programs
  • Hospital charity care policies

National Resources:

  • NeedyMeds: Medication assistance database
  • Patient Advocate Foundation: Copay relief programs
  • CureSMA: SMA-specific resources and support

For families navigating these financial challenges alongside insurance appeals, Counterforce Health can help streamline the approval process by ensuring appeals include all necessary documentation and evidence, potentially reducing delays that lead to out-of-pocket expenses.

FAQ

How long does Cigna prior authorization take for Evrysdi in Illinois? Standard review takes 5-14 business days; expedited review (for urgent cases) takes 24-72 hours. Track status via the Cigna member portal or by calling member services.

What if Evrysdi is not on Cigna's formulary? Request a formulary exception through your neurologist. Include medical necessity documentation and evidence that formulary alternatives are inappropriate or contraindicated.

Can I request expedited appeal if my child's SMA is progressing? Yes. Illinois law allows expedited appeals when delay would seriously jeopardize health. Document rapid motor decline or respiratory compromise to qualify.

Does step therapy apply if we tried Spinraza outside Illinois? Medical records from any state showing prior therapy attempts/failures should satisfy step therapy requirements. Include complete documentation of previous treatments and outcomes.

What happens if the external review approves but Cigna still won't cover? External review decisions are binding under Illinois law. If Cigna doesn't comply, file complaints with Illinois DOI immediately. The 2025 law updates include penalties up to $50,000 for non-compliance.

How do I get help with the appeal process? Contact Illinois DOI Consumer Services at (877) 527-9431, the Attorney General's Health Care Helpline at (877) 305-5145, or consider working with advocacy organizations that specialize in rare disease coverage appeals.

What documents should I keep during this process? Maintain copies of all denial letters, appeal submissions, medical records, genetic testing results, motor assessments, correspondence with Cigna, and confirmation numbers from phone calls.

Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always consult with your healthcare provider about treatment decisions and verify current coverage requirements with your insurance company. For personalized assistance with insurance appeals, contact the Illinois Department of Insurance or qualified advocacy organizations.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.